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Cherubism is a rare autosomal-dominant inherited syndrome and is usually self-limiting; it starts in early childhood and involutes
by puberty. It is a benign ﬁbroosseous disease, characterized by excessive bone degradation of the upper and lower jaws followed
by development of ﬁbrous tissue masses. The purpose of this clinical report is to describe a rare and aggressive form of cherubism
on an adult female patient that has been treated in our Bioscience Center for Special Health Care Needs-CEBAPE. The patient was
ﬁrstly submitted to the surgical procedure with partial curettage of the lesion, and the cavity was ﬁlled with autogenous cancellous
boneandbonemarrowgrafts.Furthermore,thesupporttreatmentusedwastheadministrationofsalmoncalcitoninbynasalspray
during the ﬁrst year after the preconized procedure. At 4-year followup, we conﬁrmed the stomatognathic system improvement
and esthetic rehabilitation, which led to a signiﬁcant increase in the patient’s quality of life.
1.Introduction
Cherubism is an inherited condition characterized by bone
degradation and replacement by ﬁbrous tissue at maxilla
and mandible during childhood. This disease tends to show
variable degree of remission or spontaneous involution after
puberty; nevertheless, some facial deformity may persist.
In rare cases, the disease remains active during adulthood
[1–8]. The incidence is unknown, and the age of onset is
b e t w e e n2a n d1 0y e a r so l d[ 5, 6, 8]. This abnormality is
a familial disease in which the trait is transmitted as an
autosomaldominantpattern,althoughseveralsporadiccases
withnodetectablefamilyhistoryhavebeenalreadydescribed
[9], which may be due to incomplete penetrance or new
mutations [3].
Cherubism is caused by seven mutations in the gene
encoding SH3-binding protein SH3BP2 on chromosome
4p16.3 [2, 4]. The SH3BP2 mutation is thought to lead to
parathyroid hormone receptor (PTHr) signaling and Msx-
1 activation. The gain-of-function mutation results in a
compartmentalization failure of the cap stage during molar
development leading to deregulation of bone formation and
remodelation, development of multinucleated giant cells,
and abundant deposition of ﬁbrohistiocytic tissues [4]. The
penetranceisapproximately80%(100%inmalesand50%to
70% in females), although the accurate estimate will depend2 ISRN Dentistry
on whether or not, clinical or radiological diagnostic criteria
have been used [6, 9–11].
The diﬀerential diagnosis for cherubism includes four
conditions: hyperparathyroidism, central giant-cell tumor,
ossifying ﬁbroma, and ﬁbrous dysplasia of the jaw [9, 10, 12–
14].
The physical examination of the patient aﬀected with
cherubism demonstrate a large spectrum of clinical appear-
ances, therefore, the correct diagnosis and treatment plan
depend on a well-collected data regarding the location of
the lesion, as well its histopathological and radiological
features. Even though, the disease has been researched, the
medical and dentistry community has not established a
consensus to the best form of treatment for cherubism [6,
8]. Some researchers have studied the eﬀect of calcitonin
treatment in bone metabolism and its therapeutic values
for treatment of central giant cell granuloma [15, 16]. This
hormone inhibits bone resorption, acting directly in the
osteoclastic cells [3, 4, 17], whereas other works highlight the
importanceofanautogenousbonegraftasanosteoinductive
implant material [18–21]. As seen that, the chemotactic,
mitogenic, and osteogenic potential of the autogenous bone
and bone marrow grafts associated to the presence of growth
factors and mesenquimal stem cells, have been reported by
Lieberman et al. [19] and Szpalski and Gunzburg [20]h a v e
been reported that autogenous bone and bone marrow grafts
have a chemotactic, mitogenic, and osteogenic potential.
In this present clinical study, we reported a case of one
highly debilitating aggressive cherubim in a young adult
patient, submitted to surgical procedure. The laboratorial
test results and the clinical, radiographic, and histological
features were analyzed, and we correlated these ﬁndings with
thoseoftheliterature.Additionally,thepatientwasfollowed-
up for 4 years in our Research Center after the adopted
treatment protocol, which consisted of partial curettage of
thelesion,immediateimplantationofautogenouscancellous
bone plus bone marrow grafts into the surgical bone defect,
and administration of systemic salmon calcitonin during the
ﬁrst year postoperative.
2.CaseReport
The patient under study is an 18-year-old female leuco-
derm patient who presented highly invasive, expansive, and
osteolytic lesion. Clinically, bilateral enlargement of the
face, mouth opening limited to approximately 2.0cm, and
bilateral eversion of lower vestibule were detected. The total
eruption of the right lower third molar, the partial eruption
of the left lower third molar, and total eruption of the upper
left and right third molars were evidenced. The oral mucosa
of the patient at these regions showed normal aspects.
The 3D reconstruction at the CT scan views, showed
a thin and/or eroded area in the vestibular and lingual
cortical bones of the retromolar region, exhibiting multiple
deep depressions, occurring mainly and more extensive on
the right than on the left side. However, there was an
absence of the lesion bone in the condyle processes, and
the cortical bone of the mandibular basis showed normal
Figure 1: 3D reconstruction of the CT scan images showing erosive
aspect and multiple depressions at the bilateral vestibular cortical
bone of the retromolar region (Gomes et al. [6]).
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Figure 2: Axial CT scan revealing large hypoattenuated heteroge-
nous image with aspect of expansive and invasive, osteolytic,
multilocularlesionwithperforationofthecorticalboneattheangle
and ramus of the mandible (Gomes et al. [6]).
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Figure 3: Panoramic radiograph showing bilateral growth of the
lesion in the body, ramus, and coronoid process of mandible,
atypical eruptions of the lower third molar, and resorption of the
distal root of the left lower ﬁrst molar (Gomes et al. [6]).ISRN Dentistry 3
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Figure 4: Right (a) and left (b) sides of the mandible showing lesion and the cavities without lesion ﬁlled by autogenous cancellous bone
and bone marrow graft (c) and (d), respectively.
features (Figure 1). The axial CT scan and the panoramic
radiograph showed large and a soap bubble-like cavities at
the angle and ramus of the mandible, as well as thin or
disrupted vestibular mandibular cortical bone (Figures2 and
3).Thislesionspreadfromthepremolartowardthecoronoid
process in the right and from the molar toward the coronoid
process in the left side. Moreover, there were no signs of the
lesion in the maxilla, and the lower second molars remained
surrounded by the lesion.
The results of the laboratory tests were within normal
limits for alkaline phosphatase (20lUl-I; normal: adults 13–
43lUl-I, child 56–156lUl-I), calcium (8.6mgdI-I; normal:
8.8–11.0mgdl-1), phosphorus (4.1mgdI-I; normal: adult
2.5–4.8mgdI-I, child 3–7mgdI-I), and parathyroid hor-
mone levels (21.30pgml-I; normal: 13–54pgml-I).
An incisional biopsy in the left mandibular area of
the lesion was performed, and histological sections showed
connective tissue looser and fewer multinucleated giant
cells than the ﬁrst histological examination done. Discrete
number of blood vessels, various bone trabeculae, and
o s t e o i dt i s s u ew e r ea l s op r e s e n t( F i g u r e s4(a) and 4(b)). The
clinical, radiographic, laboratory, and microscopic features
of the lesion suggested a diagnosis of diagnosis of Agressive
Cherubism.4 ISRN Dentistry
P
Figure 5: Axial CT scan showing signiﬁcant regression of the
intraosseous lesion with thick and preserved cortical bone at the
angle and ramus of the mandible.
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Figure 6: 3D reconstruction of the CT scan images showing
absence of depression and erosive areas at the mandibular body and
retromolar region.
The preconized treatment was partial curettage of the
lesion, because the total removal could result pathological
fractures and some bone cavities did not present surgical
access. The multilocular cavities without lesion were totally
ﬁlled by autogenous cancellous bone and bone marrow
grafts (Figures 4(c) and 4(d)), obtained from the patient’s
iliac crest. The supported therapy in the postoperative was
the administration of antibiotic Cefadroxil monohydrate
500mg capsules (Cefamox, Bristol-Myers Squibb, S˜ ao Paulo,
Brazil), during ten days. Immediately after the surgical
procedure, the patient was prescribed a systemic treatment
RL
Figure 7: Panoramic radiograph revealing formation and replace-
ment of the lesion by neoformed bone tissue, and the right
mandibular ramus was larger than the left side.
using daily calcitonin in the form of salmon calcitonin nasal
spray (Miacalcic, Norvatis AG, Switzerland), alternating
the nostrils, in the dosage of 200UI during the ﬁrst year
postoperative.
After surgical procedure, the patient was submitted to
radiographic examinations annually until the remission of
the lesion.
Aftersurgery,thelaboratorialresultsremainednormalto
calcium (10.4mgdl−1), phosphorus (4.1mgdl−1), parathor-
mone levels (22.9pgmg−1), and calcitonin (2.0pgmg−1;
normal/women: <5.0pgmg−1); however, there was an
increaseinthealkalinephosphatase(54IUl−1),probablydue
to progressive bone formation process.
The patient presented an expressive Postoperatory
improvement, which was preserved during all annual follow-
up assessments. These periodicals controls will be done until
the remission of the lesion. If the lesions do not go into a
complete spontaneous remission, a complementary surgery
could be performed.
A future appointment will be scheduled for the extrac-
tion of the remaining unerupted teeth in order to avoid
further development of cyst and/or odontogenic tumors.
3. Discussion
The cherubism’s treatment depends on the rate of pro-
gression of the lesion, extension of tissues involved, and
emotional state of the patient. The general recommendation
from previous studies is to postpone the treatment until
after puberty, unless severe psychological and physiologic
dysfunctions impose an early intervention [2, 3, 10]. The
literature review highlights a couple of considerations to be
made when considering the treatment plan of an aggressive
appearance of the cherubism. As reported by several authors,
depending on the aggressiveness of the cherubism, can
occur occur perforation of the cortical bone, weakening the
area, which becomes more susceptible to fractures and/or
infections [2, 10, 11]. Meanwhile, other studies remind
us that the dental practitioner should be alert to the risk
of promoting serious mutilation of the jaw and, hence,
to the face when performing a surgery in an exacerbated
form of cherubism—recommending, especially in these
patients, systemic calcitonin administration as an attractiveISRN Dentistry 5
and eﬀective clinical therapy for larger lesion, relying on its
eﬀectofinhibitingtheosteoclasticactivityand,consequently,
inhibiting of the bone resorption [14, 16, 21]. In this case
report, the lesion reached worrisome proportions risking an
imminent pathological fractures, besides thrive and speech
impairment,andpsychologicaldisturbance,leadingtheteam
to opt for the immediate surgical intervention.
In this case report, the patient was submitted to a
conservative partial curettage of the lesion, and surgical
defectswereﬁlledwithautogenouscancellousboneandbone
marrow grafts. The removal of the second molar involved
in the lesion was not possible to execute during the surgery
due to the risk of bone fracture, although its extraction
will be executed on a further appointment. Several works
pointouttheimportanceofanautogenousbonegraft,which
is an osteoinductive and osteoconductive material [18–21],
promoting the acceleration of bone repair. Probably, This
factoccursduetothechemotactic,mitogenic,andosteogenic
activityoftheautogenouscancellousbone,andbonemarrow
grafts are associated with the presence of growth factors and
autologous marrow-derived mesenchymal stem cells [19, 20,
22, 23]. We inferred that this could account for the presence
of newly formed bone trabeculae in the graft areas, as well as
the repairment of the remaining lesion areas by neoformed
bone. Besides, the bone matrix is also rich in other growth
factors such as bone morphogenetic proteins (BMPs), trans-
forming growth factor-beta (TGF-beta), ﬁbroblast growth
factor (FGF), platelet-derived growth factor (PDGF), and
epidermal growth factor (EGF) [19, 20, 22]. In addition,
the salmon calcitonin was used concomitantly to inhibit
multinucleated giant cells formation, osteoclast activity and
proliferation, inﬂuencing in the regressive process of the
lesion.
The biochemical examinations were within the normal
range on our patient. However, it was demonstrated that
alkaline phosphatase was increased, suggesting bone forma-
tion process and, consequently, remission of the lesion.
In brief, this clinical case reports an aggressive form of
cherubism whereas the surgical procedure was prescribed
due to psychological and physiological damage installed.
We assessed that the combination of the osteoinductive
and osteoconductive material, as autogenous cancellous
bone and bone marrow grafts, plus systemic calcitonin was
eﬀective in this aggressive cherubism’s clinical management,
building up strength to the bone repair process (Figures 5, 6,
and 7). Despite the encouraging results obtained in this case
report, we emphasize that future clinical studies are needed
to address whether the combined therapy actually improved
the healing process.
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